Macrogen, Inc.

Macrogen, Inc. is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. Through its subsidiary Psomagen Inc., the company offers a wide range of advanced sequencing technologies and data analysis solutions to support research in fields such as genetics, agriculture, and biomedical science. Macrogen, Inc. specializes in delivering high-quality sequencing data and comprehensive bioinformatics services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and the Food and Drug Administration (FDA).

The company has been awarded numerous federal contracts to provide a diverse array of genomic services. These include whole genome sequencing, RNA sequencing, epigenome sequencing, single-cell multiome sequencing, and microarray services. Macrogen, Inc. has supported research on topics such as neurodegenerative diseases, COVID-19, agricultural genetics, and cancer through its contract work. Notable projects include sequencing wheat samples for the USDA Agricultural Research Service, performing whole genome sequencing for the National Institute on Aging's Alzheimer's disease research, and providing DNA and RNA sequencing services for the National Cancer Institute. Many of these contracts have been awarded to Psomagen Inc. as a small business, with several set aside specifically for small business participation.

Macrogen, Inc., through its subsidiary Psomagen Inc., holds two significant Indefinite Delivery Vehicles (IDVs) with federal agencies. The first is an IDV with the USDA, which allows for the provision of sequencing and large-scale omics data analysis services to support agricultural research initiatives. The second is a major IDV awarded by the National Heart, Lung, and Blood Institute, valued at up to $500 million, to establish and operate the Centralized Omics Resource. This resource performs multi-omics analysis and data integration to enable precision medicine approaches through the Trans-Omics for Precision Medicine (TOPMed) initiative. These IDVs demonstrate Macrogen's capacity to provide comprehensive genomic services on a large scale to support critical federal research programs in both agricultural and biomedical fields.